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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
#DisabilityC19 Twitter chat 
Pregel, A. | Sightsavers | 7 April 2020 | Blog 
https://www.sightsavers.org/blogs/2020/04/disabilityc19-twitter-
chat/?utm_source=twitter&utm_medium=referral&utm_content=disabilityc19&utm_campaign=poli
cy 
The #DisabilityC19 Twitter chat run by ARISE on 6 April included conversations about the greater 
risk people with disabilities face, how to make the global response more inclusive, stigma and 
discrimination, and the impact on daily life for people with disabilities and how to not leave them 
behind. This blog summarises the main points from the chat. 
CBM develops ‘Disability Inclusive Community Action – COVID-19 Matrix’ 
CBM | 30 March 2020 | Tool 
https://www.cbm.org/news/news/news-2020/cbm-develops-disability-inclusive-community-action-
covid-19-matrix/ 
This matrix aims to provide community programmes guidance on potential action points in 
community development and mobilisation to prepare and respond to COVID-19. It can be adapted 
to local context. 
School closure and management practices during coronavirus outbreaks including 
COVID-19: a rapid systematic review 
Viner et al. | The Lancet Child & Adolescent Health | 6 April 2020 | Review 
https://doi.org/10.1016/S2352-4642(20)30095-X 
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In response to the COVID-19 pandemic, 107 countries closed schools nationally by 18 March 
2020. Data from the SARS outbreak in mainland China, Hong Kong and Singapore suggest that 
school closures did not contribute to the control of the epidemic. Recent modelling studies of 
COVID-19 predict that school closures alone would prevent only 2 to 4% of death, much less than 
other social distancing interventions. Studies are needed of countries that have not implemented 
school closures and as closed schools begin to reopen on the numbers of COVID-19 cases. Other 
school social distancing interventions that are less disruptive than full school closure should be 
looked into to maintain the control of this pandemic. Note that school closure can have impact 
alongside other lockdown measures.  
Effectiveness of surgical and cotton masks in blocking SARS-CoV-2: a controlled 
comparison in 4 patients 
Bae et al. | Annals of Internal Medicine | 6 April 2020 | Letter 
https://doi.org/10.7326/M20-1342 
Both surgical and 100% cotton masks seem to be ineffective in preventing the dissemination of 
SARS-CoV-2 from coughs of patients with COVID-19 to the environment and external mask 
surface. This experiment did not include N95 masks and further study is needed to recommend 
whether face masks decrease transmission of virus from asymptomatic individuals or those with 
suspected COVID-19 who are not coughing. 
Facemasks and similar barriers to prevent respiratory illness such as COVID-19: a rapid 
systematic review 
Brainard et al. | MedRxiv pre-print server | 6 April 2020 | Preprint 
https://www.medrxiv.org/content/10.1101/2020.04.01.20049528v1 
This non-peer reviewed rapid, systematic review suggests that the evidence is not sufficiently 
strong enough to support widespread use of facemasks as a protective measure against COVID-
19 but that there is enough evidence to support the use of facemasks for short periods of time by 
vulnerable individuals when in transient higher risk situations. Trials are needed to determine if 
wearing a facemask in the community is protective against COVID-19. 
Sample pooling as a strategy to detect community transmission of SARS-CoV-2 
Hogan et al. | JAMA | 6 April 2020 | Research Letter 
https://doi.org/10.1001/jama.2020.5445 
The strategy of sample pooling, used for community monitoring of other infectious diseases, was 
assessed to increase test throughput, limit use of reagents, and increase overall test efficiency for 
early comprehensive screening of SARS-CoV-2 in the United States. This study found that pooled 
screening may facilitate detection of early community transmission of SARS-CoV-2 and enable 
timely implementation of appropriate infection control measures to reduce spread. 
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Maintaining HIV care during the COVID-19 pandemic 
Jiang et al. | The Lancet HIV | 6 April 2020 | Comment 
https://doi.org/10.1016/S2352-3018(20)30105-3 
This Comment addresses challenges to continuing HIV care during the COVID-19 pandemic 
including reduced access to routine HIV testing, timely linkage to HIV care and ART 
discontinuation. WHO, UNAIDS, and the Global Network of People Living with HIV are working 
together to ensure continued provision of HIV prevention, testing and treatment services. This 
includes access to antiviral drugs at local designated centres or by post; dispensing of antiviral 
drugs in 3 to 6 month doses to reduce facility visits and community outreach. Partnership between 
governments, community-based organisations and international partners should ensure timely 
access to, and to avoid disruption of, routine HIV services. 
Few clinical trials are done in Africa: COVID-19 shows why this urgently needs to change 
Mabuka-Maroa, J. | African Academy of Sciences | The Conversation | 6 April 
https://theconversation.com/few-clinical-trials-are-done-in-africa-covid-19-shows-why-this-
urgently-needs-to-change-135117 
A search of the US NIH online globally registered COVID-19 clinical trial platform found a low 
representation of African countries. Outcomes of the COVID-19 studies may not be relevant for 
people in African countries unless conducted locally. African governments need to harmonise their 
response across the continent; provide additional funding to clinical research institutions and 
clinical trial sites; adopt a ‘hub-and-spoke’ model where countries that don’t have much capacity 
can ship samples easily across borders for analysis in a centralised well-equipped laboratory, 
when then feeds back data to the country of sample origin. Clinical trial centres, clinical research 
institutions and clinical traillists in Africa should increase their visibility in the global space and the 
AAS is currently building an online platform to increase this visibility and encourage greater 
collaboration. 
COVID-19: How countries can use digital payments for better, quicker cash transfers 
Gelb, A. & Mukherjee, A. | Center for Global Development | 6 April 2020 | Commentary & Analysis 
https://www.cgdev.org/blog/covid-19-how-countries-can-use-digital-payments-better-quicker-
cash-transfers 
Countries are expanding and introducing social support programmes in response to mass 
unemployment and social disruption as economies shut down to limit COVID-19 transmission. 
Cash transfers are the most widely used social assistance intervention by governments, with 54 of 
71 countries specifically introducing initiatives as a response to COVID-19. The immediate 
challenge is how to make government-to-people (G2P) transfers efficiently, equitably, and at scale 
and this Commentary discusses how technology can be used to do so.   
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Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
Johns Hopkins University COVID-19 dashboard in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467
b48e9ecf6 
Vaccine Centre, LSHTM  
https://vac-lshtm.shinyapps.io/ncov_tracker/ 
This site complements the WHO and Johns Hopkins University COVID-19 dashboards by 
including the timeline functions, the ability to overlay past outbreaks, and an emphasis on 
normalised counts (per 100,000 individuals). 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected countries 
http://globalhealth5050.org/covid19 
Africa 
Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
UK 
COVID-19: PHE track coronavirus cases in the UK 
https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases 
UK case tracing infographic 
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4bb14 
Online learning  
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
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https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging 
respiratory viruses, including novel coronaviruses, and how to effectively respond to an outbreak. 
Intended for public health professionals, incident managers and personnel working for the UN, 
international organisations and NGOs. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
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A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
Resource Hubs 
International Disability and Development Consortium and CORE Group: Repository of 
resources on disability inclusion and COVID-19 
https://docs.google.com/document/d/1IVP1u6yHfLuN9qNyLEct5-vtC0aqLKtKr-o-
faAjves/edit 
 
US NIH online platform of all registered, ongoing clinical trials globally 
https://clinicaltrials.gov/ct2/results?cond=COVID-19 
COVID-19 Narratives by Dr David Nabarro 
https://www.4sd.info/covid-19-narratives/ 
These narratives are being written by David Nabarro, Co-Director of the Imperial College Institute 
of Global Health Innovation at Imperial College London, Strategic Director for 4SD and one of six 
Special Envoys to the WHO DG Special Envoy on COVID-19, and peers to share with those who 
want more information about the situation and to help raise the awareness and readiness of all 
actors. Please visit WHO website for official guidance.  
Reliefweb COVID-19 
https://reliefweb.int/topics/covid-19 
Coronavirus global health emergency 
https://www.un.org/coronavirus 
Norwegian Institute of Public Health: Live map of COVID-19 evidence 
https://www.fhi.no/en/qk/systematic-reviews-hta/map/ 
Overview of scientific publications on COVID-19 categorised into subgroups to provide quick 
access to specific topic-relevant publications to help decision makers and research navigate the 
research and help identify research gaps.  
Vaccine Centre at LSHTM: COVID-19 vaccine development pipeline tracker 
https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/ 
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COVID-19 Research Project Tracker by UKCDR & GloPID-R 
https://www.ukcdr.org.uk/funding-landscape/covid-19-research-project-tracker/ 
A live database of funded research projects across the world related to COVID-19 mapped against 
the priorities identified in the WHO Coordination Global Research Roadmap: 2019 Novel 
Coronavirus. 
WHO Q&A on COVID-19 
https://www.who.int/news-room/q-a-detail/q-a-coronaviruses 
Note that this resource includes Q&A on COVID-19; COVID-19, pregnancy, childbirth and 
breastfeeding; COVID-19, HIV and antiretrovirals; similarities and differences COVID-19 and 
influenza; mass gatherings and COVID-19; IPC for healthcare workers; COVID-19 and food and 
agriculture; smoking and COVID-19; malaria and COVID-19. 
COVID-19: Resources and research on epidemics and pandemics 
https://steps-centre.org/covid-19-coronavirus-resources-research-epidemics-pandemics/ 
Stop TB Partnership TB and COVID-19 
http://www.stoptb.org/covid19.asp 
EPI-WIN: WHO information network for epidemics: COVID-19 public health emergency 
https://www.who.int/teams/risk-communication 
COVID-19: Research ethics 
https://ethicsresource.ringsgenderresearch.org/covid-19-resources/ 
LSTM: COVID-19 
https://www.lstmed.ac.uk/covid-19 
LSHTM: COVID-19 
https://www.lshtm.ac.uk/research/research-action/covid-19 
International Disability Alliance: COVID 19 and the disability movement 
http://www.internationaldisabilityalliance.org/content/covid-19-and-disability-movement 
Africa Centres for Disease Control and Prevention (Africa CDC) 
https://africacdc.org/covid-19/ 
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UNICEF: Latest news and updates on coronavirus disease 2019 (COVID-19) 
https://www.unicef.org/coronavirus/covid-19 
Coronavirus: the science explained 
https://coronavirusexplained.ukri.org/en/ 
Social Science in Humanitarian Action: Updates on the novel COVID-19 outbreak 
https://www.socialscienceinaction.org/update-novel-covid-19-outbreak/ 
Special Collection: Coronavirus (COVID-19): evidence relevant to critical care 
https://www.cochrane.org/news/special-collection-coronavirus-covid-19-evidence-relevant-
critical-care 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-
coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.htmlThe Global Health Network Coronavirus 
outbreak knowledge hub 
9 
The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campaign=
DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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